drugset / Trial / NCT00495170

Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

NCT00495170 ↗

Phase 2 Completed 84 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn if proton radiotherapy given with standard chemotherapy (such as paclitaxel and carboplatin) can help to control locally advanced NSCLC. The safety of this treatment will also be studied.

Timeline

Start
2006-04-14
Primary completion
2017-06-14
Completion
2017-06-14

Drugs

EvaluationDrugModalityDoseRoute
Background Carboplatin Small molecule 2 unknown Intravenous
Background Paclitaxel Small molecule 50 mg/m2 Intravenous

Indications